Rapid Clinical Advice on new TB drugs in children

The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.

The Rapid Clinical Advice was produced by a global committee of 18 clinicians who are experts in the management of multidrug-resistant TB (MDR-TB) in children.

The document is meant to complement the Sentinel Project’s Field Guide on the management of MDR-TB in children (available here) and synthesize timely clinical guidance on the use of new drugs for providers who are caring for children with drug-resistant TB.

Rapid Clinical Advice: The Use of Bedaquiline and Delamanid for Children with Drug-Resistant Tuberculosis is available as a PDF here.

Source: Sentinel Project

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Published: May 18, 2016, 7:12 a.m.

Last updated: May 20, 2016, 11:14 a.m.

Print Share